TY - JOUR
T1 - Sustainable cancer therapy
AU - Zhao, Yuan Yuan
AU - Lee, Sungkyu
AU - Lee, Yeju
AU - Hwang, Bokyeong
AU - Jung, Hwapyung
AU - Hu, Qiongzheng
AU - Song, Guosheng
AU - Kang, Heemin
AU - Yoon, Juyoung
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/9
Y1 - 2025/9
N2 - Sustainable cancer therapy, achieved through the activation of molecules or nanoparticles that initiate long-term cancer-therapeutic actions, has attracted increasing attention in recent years. Numerous pre-clinical and clinical investigations have shown that sustainable cancer treatments can effectively trigger tumor regression. Currently, near-infrared light, X-rays, and ultrasound stimuli are extensively employed to trigger long-term therapeutic effects. In particular, X-rays and ultrasound possess significant potential for deep tumor therapy due to their excellent tissue penetration capabilities, which can boost treatment efficacy. Notably, long-term photonic and ultrasound activation can be synergistically combined with various therapies, such as sonodynamic therapy, photothermal therapy, photodynamic therapy, and immunotherapy, to further enhance therapeutic efficacy. Additionally, chemodynamic therapy enables synergistic dual activation, including cyclic and switchable reactions, to elicit a sustained therapeutic effect. This review encapsulates recent methodologies and benefits of sustainable cancer treatment, particularly for intractable tumors, and underscores that sustained cancer treatment can incorporate long-term self-powering, autonomous control, and self-replenishing functions. Crucially, the challenges and future outlooks of stimuli-responsive sustainable cancer therapy are examined to foster its advancement and clinical applications.
AB - Sustainable cancer therapy, achieved through the activation of molecules or nanoparticles that initiate long-term cancer-therapeutic actions, has attracted increasing attention in recent years. Numerous pre-clinical and clinical investigations have shown that sustainable cancer treatments can effectively trigger tumor regression. Currently, near-infrared light, X-rays, and ultrasound stimuli are extensively employed to trigger long-term therapeutic effects. In particular, X-rays and ultrasound possess significant potential for deep tumor therapy due to their excellent tissue penetration capabilities, which can boost treatment efficacy. Notably, long-term photonic and ultrasound activation can be synergistically combined with various therapies, such as sonodynamic therapy, photothermal therapy, photodynamic therapy, and immunotherapy, to further enhance therapeutic efficacy. Additionally, chemodynamic therapy enables synergistic dual activation, including cyclic and switchable reactions, to elicit a sustained therapeutic effect. This review encapsulates recent methodologies and benefits of sustainable cancer treatment, particularly for intractable tumors, and underscores that sustained cancer treatment can incorporate long-term self-powering, autonomous control, and self-replenishing functions. Crucially, the challenges and future outlooks of stimuli-responsive sustainable cancer therapy are examined to foster its advancement and clinical applications.
KW - Autonomous control
KW - Cancer therapy
KW - Cyclic activation
KW - Long-term self-powering
KW - Self-replenishing function
UR - https://www.scopus.com/pages/publications/105008817174
U2 - 10.1016/j.mattod.2025.06.011
DO - 10.1016/j.mattod.2025.06.011
M3 - Review article
AN - SCOPUS:105008817174
SN - 1369-7021
VL - 88
SP - 705
EP - 729
JO - Materials Today
JF - Materials Today
ER -